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Abstract 
 
Ryan Shanks 
RGS Domain-independent Sst2 action 
(Under the Direction of Henrik Dohlman Ph.D) 
 
RGS proteins are a family of proteins that share a conserved RGS domain that 
contacts Gα to accelerate GTP hydrolysis. It is thought that the function of RGS 
proteins lies not only in the RGS domain, but also through interactions mediated 
by domains outside of this region.  Other than its RGS domain, the yeast RGS 
protein Sst2 contains two DEP domains. It has been shown that the DEP 
domains of Sst2 facilitate binding between Sst2 and the GPCR Ste2. The 
presumed function of this binding is to target Sst2 GAP activity towards the 
mating pathway Gα.  Here, we show an additional function of the DEP domains 
of Sst2 that is independent of GAP activity. Expression of only the N-terminal 
DEP domains of Sst2 dampens the mating response. We present preliminary 
data testing two potential mechanisms of this action, and conclude with a 
discussion of the future directions of this work. 
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Introduction: 
Heterotrimeric G-protein signaling is involved in multiple vital functions such as 
embryogenesis, photo-transduction, and neurotransmission1, 2.  The 
pharmacological and clinical relevance of G-protein signaling is underscored by 
the fact that most current medications target G-protein mediated signaling2, 3.  
RGS proteins inactivate G-protein signaling, and as such have emerged as 
possible drug targets for multiple diseases, mostly involving the CNS4,6.  Indeed, 
aberrant RGS function has been linked to Schizophrenia and Parkinson’s 
disease7-10.  Thus, a better understanding of RGS function may guide the 
development of RGS-directed therapeutics. 
Heterotrimeric G-proteins consist of Gα, Gβ, and Gγ subunits (Fig. 1)(reviewed)1-
2.  Upon activation by G-protein coupled receptors (GPCRs), Gα exchanges GDP 
for GTP causing heterotrimer dissociation and signal propagation through Gα, 
Gβγ, or both.  Gα subunits have intrinsic GTPase activity, which catalyzes the 
hydrolysis of GTP to GDP resulting in re-association of Gα with Gβγ.  This 
GTPase activity is dramatically enhanced by RGS proteins, which work as 
GTPase accelerating proteins (GAPs). All RGS proteins possess a conserved 
120 amino acid RGS domain that contacts with Gα to stabilize the transition state 
for GTP hydrolysis. Homology outside of this RGS box varies widely for each 
family of RGS proteins.  While much is known about the in vitro ability of an RGS 
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protein to work as a GAP against specific Gα subtypes, RGS proteins 
demonstrate selectivity in vivo that would not be predicted by in vitro work11. RGS 
proteins are thought to achieve this in vivo selectivity through differential tissue 
expression and protein-protein interactions mediated by domains outside of the 
conserved RGS box11-13. In order to develop therapeutics towards RGS proteins, 
it will be important to understand the function of such domains.   
The yeast Saccharomyces cerevisiae was vital to the discovery of RGS 
proteins14, 15.  Yeast continue to serve as a valuable model for studying G-protein 
signaling due to conserved G-protein signaling components and ease of genetic 
manipulation.  Unlike mammalian systems, in yeast it is common practice to 
delete native genes and express mutants as single copies under the control of 
their native promoters.  The ease of gene deletion is made possible by the high 
rate at which yeast undergo homologous recombination.  Expression of mutants 
as single copies under native promoters avoids the inherent difficulties in 
interpreting data from overexpression systems.  Here, I have used yeast as a 
model of G-protein signaling in order to better understand RGS function. 
In yeast, activation of the GPCR Ste2 by pheromone leads to a mating response 
that involves activation of a MAP kinase cascade, transcriptional induction of 
mating responsive genes, cell cycle arrest, and formation of a polarized mating 
tip (termed shmoo)16.  Together these events provide a mechanism through 
which yeast can sense the presence of, grow towards, and fuse with a mating 
partner (Fig. 2).   
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In the yeast RGS protein Sst2, a DEP domain confers binding to the upstream 
GPCR Ste217. The presumed purpose of this binding is to localize Sst2 towards 
the site of activation of the mating Gα Gpa1, which is activated by Ste2. It is also 
possible that RGS / GPCR binding mediates a GAP-independent function of 
Sst2.  Indeed, previous work with a version of Gpa1 that Sst2 can neither bind to, 
nor work as a GAP against suggests that Sst2 might have a GAP-independent 
effect on the mating pathway18.  Here, we use several reagents available in yeast 
to demonstrate that the DEP domains of Sst2 dampen mating response 
independently of GAP activity.  We go on to present a framework of future 
experiments and preliminary data aimed at determining the mechanism of this 
GAP-independent action.   
Results: 
The DEP domains of Sst2 dampen mating response independent 
of GAP activity: 
It was recently demonstrated that the DEP domains of Sst2 facilitate binding to 
the GPCR Ste217.  This binding is required for full Sst2 action17.   However, it is 
unknown if Sst2/Ste2 binding is required for proper targeting of Sst2 GAP activity 
to the site of heterotrimer activation, or due to a mechanism independent of GAP 
activity.  To test this, we constructed an Sst2 truncation mutant containing both 
DEP domains of Sst2 but lacking the RGS box (termed N-Sst2, Fig 3A)19.  We 
presume that this fragment of Sst2 lacks GAP activity due to its absence of an 
RGS box, and due to recent demonstration that the C-terminus of Sst2 alone is 
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capable of working as a GAP against Gpa120.  Nonetheless, this is a question we 
are currently addressing with the help of a collaborating lab. 
To determine if DEP-mediated dampening of the mating response requires GAP 
activity, we performed a Halo assay in yeast lacking Sst2 (sst2Δ) transformed 
with either N-Sst2 or an empty vector. This assay measures the sensitivity of 
each strain to equal pheromone amounts spotted on a paper disc.  Because 
mating pathway activation leads to cell cycle arrest, pheromone sensitivity is 
evident as the size of growth inhibition (halo) around the paper disc.  As shown in 
Figure 3, sst2Δ strains expressing N-Sst2 show diminished halo size at all doses 
of alpha factor when compared to sst2Δ strains expressing only an empty vector.     
Thus, N-Sst2 dampens mating response to alpha factor in a fashion that is 
independent of wild type Sst2 expression. 
To obtain a more quantitative picture of N-Sst2 action on the mating response we 
measured mating pathway activation with a pheromone-dependent transcription 
reporter assay.   This assay employs a lacZ reporter fused to the promoter of a 
pheromone specific gene (FUS1).  When compared to wild type, cells lacking 
Sst2 demonstrate elevated basal pathway activity and a leftward shift of the dose 
response curve (Figure 4).  Cells lacking Sst2 were transformed with either an 
empty vector or a single copy plasmid expressing N-Sst2.  As shown in Figure 5, 
expression of N-Sst2 dampens the basal pathway activity typically observed in 
yeast lacking Sst2.  As evidenced by the full dose response seen in Fig 6, 
expression of N-SST2 decreases maximal activation when compared to sst2Δ.  
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This data demonstrates that N-Sst2 is capable of partially reversing the 
supersensitive phenotype observed in cells lacking Sst2. 
We went on to test the effects of N-Sst2 on MAPK activation.  In response to 
pheromone, a MAPK cascade is activated that results in phosphorylation of the 
activation loop of two MAPKs, Fus3 and Kss1.  We used an antibody specific for 
the dually phosphorylated, fully active form of Fus3 and Kss1 to monitor the 
activation kinetics of Fus3 and Kss1.  Cells lacking Sst2 were transformed with 
either an empty vector or a single copy of N-Sst2 and treated with 3 uM alpha 
factor.  As shown in Figure 7, cells expressing N-Sst2 showed diminished MAPK 
activation when compared to sst2Δ.  This is consistent with the diminished cell-
cycle arrest and transcription reporter activity we have presented above.  Taken 
together, these data suggest that the N-terminal DEP domains of Sst2 are 
capable of dampening the pheromone response independently of GAP action.  
What is the mechanism of N-SST2 action? 
Having established a GAP-independent role of Sst2’s DEP domains, we wanted 
to determine the mechanism of this action.  There are multiple ways through 
which the DEP domains of Sst2 could dampen the mating response. This region 
of Sst2 binds to the C-terminal tail of the GPCR Ste2.  This is the same region of 
the receptor that binds to Gpa1 in a pre-activation complex21.  Thus, N-Sst2 
could compete with Gpa1 for receptor binding.  When bound to Ste2, it is also 
possible that N-Sst2 alters receptor exchange activity, limits receptor 
phosphorylation, or recruits another molecule to the site of heterotrimer 
activation.  Lastly, it is possible that N-Sst2 does not require receptor binding to 
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limit pathway activation. Large-scale screens have identified several potential 
Sst2 binding partners22-26.  Of particular interest is an interaction with the 
osmosensor Sho1 that has been further supported by co-immunoprecipitation 
experiments performed in our lab (Nan Hao, unpublished data).  Sho1 activates a 
MAPK pathway that shares many components with the mating response MAPK 
cascade, most notably the same MAPKKK Ste1127.  As the possible mechanisms 
of N-Sst2 action fall into two broad categories, those that require receptor binding 
and those that do not, our first goal was to determine if N-Sst2 action requires 
receptor binding. 
To test if N-Sst2 action requires receptor binding, we constructed versions of N-
Sst2 containing point mutations at residue 304 (Q304L, Q304N, and Q304E).  
These mutations have been shown to abolish binding between Sst2 and Ste217. 
Our plan was to test if these versions of N-Sst2 that do not bind to Ste2 can still 
dampen basal transcription reporter activity. Unfortunately, we found a large 
variation in basal activity in these mutants (Figure 8).   When we performed 
western blots to determine expression of these constructs, we found that none 
has expression similar to native N-Sst2 (Figure 9).  To increase expression, we 
have now inserted N-Sst2Q304N  into a multi-copy plasmid. We will go on to test 
expression of this construct and test the receptor binding dependence of N-Sst2 
action. 
We also have started to ask if Sho1 binding is required for N-Sst2 action. Due to 
shared pathway components between the osmosensing pathway initiated by 
Sho1 and the mating pathway, this would be the most obvious way N-Sst2 could 
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work independently of receptor binding.   To determine if Sho1 is required for N-
Sst2 action, we expressed either empty vector or N-Sst2 in cells lacking both 
Sho1 and Sst2.  We then measured transcription reporter activity to determine if 
deletion of Sho1 rescues the N-Sst2 phenotype.  As shown in Fig 10, in the 
absence of Sho1, N-Sst2 is no longer able to dampen basal pheromone 
signaling. We have confirmed by western blot that N-Sst2 is expressed in this 
genetic background.  We should note that this figure represents a single 
experiment and attempts to repeat this experiment have failed. Our problem in 
repeating this experiment is likely due to the reporter construct that must be used 
in this strain (due to selection marker availability).  Nonetheless, if this result 
proves to be true, it would suggest that Sho1 is required for N-Sst2 action. 
Discussion: 
RGS proteins are considered potential drug targets in the CNS and 
cardiovascular system and have been studied extensively4, 6.  While much is 
known about the role of the RGS domain in determining the selectivity and action 
of RGS proteins, our knowledge of the function of domains outside of the RGS 
box remains incomplete.  This knowledge will be required for development of 
RGS-targeted therapeutics. 
Here, we have identified a function for the DEP domains of the yeast RGS 
protein Sst2 that is independent of its RGS domain.  We have used multiple 
assays to demonstrate that the DEP domains of Sst2 dampen the mating 
response to pheromone. This finding is further supported by previous work that 
demonstrates Sst2-mediated pathway dampening in an RGS insensitive  Gpa1 
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mutant18.  While it is clear that the effect of N-Sst2 does not represent the entire 
function of Sst2, it is equally clear that this effect is not negligible, particularly in 
regulation of basal pathway activity.  Importantly, basal pathway activity present 
in cells lacking Sst2 is sufficient to cause formation of mating projections 
(shmoos)28.  As the data presented here shows a greater than 50% reduction in 
basal pathway activity, it seems possible that the major function of N-Sst2 is to 
limit aberrant pathway activation in the absence of pheromone.    
Previous work has demonstrated that Sst2 is proteolytically cleaved in vivo at 
Ser-414 and Ser-416 to yield two products: the C-terminal RGS domain, and the 
N-terminal half of the protein containing 2 DEP domains19. While the function and 
regulation of this processing remains unclear, the fact that these cleavage 
products exist naturally would argue against our findings with N-Sst2 being due 
to an artifact caused by overexpression of a non-native protein.  Additionally, this 
previous work also shows a decrease in basal and maximal activity as measured 
by transcriptional reporter assay19. This likely went unnoticed by the authors due 
to the relatively small magnitude of difference observed in their work19.  It is likely 
that the difference in magnitude of the N-Sst2 effect observed here is due to the 
use of a more sensitive assay for β-galactosidase activity.  
The mechanism of N-Sst2 action remains unknown.  Until this point, it has been 
assumed that any function of this region of Sst2 involves coordination and 
targeting of the GAP action encoded by Sst2’s RGS box.   However, the data 
presented here demonstrates a GAP-independent dampening of Sst2 on the 
mating pathway.  While there are a large number of possible mechanisms 
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through which N-Sst2 could work, it is likely that these mechanisms fall into two 
main categories: those that require binding to Ste2 and those that don’t.  As 
such, our first priority is to determine if Ste2 binding is required for N-SST2 
action.  As shown in Fig 8, the low expression of the non-receptor binding 
mutants of N-Sst2 might limit the utility of these experiments.  Nonetheless, our 
preliminary work has shown that even in cases of low protein abundance, a non-
receptor binding mutant of N-Sst2 (N-SST2Q304N) is capable of dampening basal 
pathway activity (Figure 8).  This would suggest that receptor binding is not 
required for N-Sst2 action.  Given this preliminary data, we feel confident that 
insertion of N-Sst2Q304N into a multi-copy plasmid that will provide a more similar 
protein abundance to N-Sst2wt will reveal whether N-Sst2 action requires Ste2 
binding.   
However, another approach that may be useful in determining the role of 
receptor binding in N-Sst2 action would be to promote N-Sst2 binding to Ste2. N-
Sst2/Ste2 binding is abolished by Ste2 phosphorylation, which occurs at a 
significant level in the absence of pheromone29.  Alanine mutation of the 19 
serine and threonine residues within the last 100 amino acids of the C-terminal 
tail of Ste2 (Ste2A19) causes constitutive Sst2/Ste2 binding17.  If receptor binding 
is required for N-Sst2 action, constitutive receptor binding would be predicted to 
further dampen basal pathway activity.  As mutation of Ste2 phosphorylation 
acceptor residues not only alters N-Sst2/Ste2 binding but also Ste2 endocytosis, 
we have introduced these alanine substitutions into an endocytosis-resistant form 
a Ste2 (Ste27KR).  Comparison of N-Sst2 action in this endocytosis resistant 
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background should eliminate any effects of the alanine substitutions on receptor 
endocytosis. As such, comparison of two versions of Ste2 that differ only in their 
level of Sst2 binding might reveal whether N-Sst2 action requires receptor 
binding. 
If these experiments suggest that receptor binding is required for N-Sst2 action, 
we would further seek to determine the how N-Sst2 dampens pathway activation. 
There are multiple receptor-dependent mechanisms through which N-Sst2 could 
work.  As discussed previously, N-Sst2 could compete with Gpa1 for Ste2 
binding, alter Ste2 exchange activity, alter Ste2 C-terminal tail phosphorylation, 
or recruit another molecule to the site of heterotrimer activation. These 
mechanism can be tested with Ste2/Gpa1 co-immunoprecipitation experiments, 
Ste2 exchange assays from yeast membrane preparations, Ste2 metabolic 
labeling, or through a screen of known Sst2 binding partners, respectively. 
If the above experiments suggest that receptor binding is not required for N-Sst2 
action it would limit the possible mechanisms through which N-Sst2 could 
function.  Fortunately, several systematic screens have identified 26 possible 
Sst2 binding partners17, 22-26.  To begin to determine the mechanism of N-Sst2 
action, our approach would be to determine if deletion of any of these possible 
Sst2 interaction partners rescues the N-Sst2 phenotype.  Because the strongest 
effect of N-Sst2 we have observed is on basal transcription reporter activity (Fig 
5), we would use this as positive control for N-Sst2 action.  While a systematic 
screen of each of these proteins is most likely to elucidate the mechanism of N-
Sst2 action, we have already begun to test one the possible targets, the 
 11 
osmosensor protein Sho1.  This protein is a particularly likely candidate for N-
SST2 action because the pathway it activates (the high osmolarity glycerol 
pathway) shares many of the same components as the mating pathway, most 
prominently the MAPKKK Ste1127.  While our initial work will need to be 
confirmed, the data presented in Figure 10 does suggest that this might be a 
promising area of investigation.  If Sho1 is required for N-Sst2 action we would 
go on to confirm physical interaction with co-immunoprecipitation experiments 
and determine the region of Sho1 that Sst2 binds to.  Of particular interest in 
mediating the Sho1/N-Sst2 interaction is the cytoplasmic C-terminal tail of Sho1. 
Here, we have identified a previously unknown function for the DEP domains of 
Sst2.  We have gone on to present initial data and a framework for determining 
the mechanism of N-Sst2 action.  Much is still left to be known about RGS 
protein selectivity and action and the function of DEP domains.  Hopefully, our 
demonstration of a GAP-independent effect of Sst2 will inform future studies in 
these areas. 
Methods: 
Strains:  All strains were derived from BY4741 (MATa leu2Δ met15Δ his3Δ 
ura3Δ).  The sst2Δ strain was constructed with a KanMX G418 deletion cassette 
(Research Genetics).  The sho1Δsst2Δ strain was constructed by integration of 
an Sst2 deletion cassette containing the HIS3 gene (gift from Dr. David Drubin) in 
a sho1Δ G418 strain.  Deletion of Sst2 was confirmed by the Halo assay and 
immunoblots for Sst2. 
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Plasmids:  Plasmids pRS315-ADH-N-SST2 and pRS423-FUS1-lacz have been 
previously described19.  pRS315-ADH-N-SST2Q304N, Q304E, and Q304L were made 
from pRS315-N-SST2 using site directed mutagenesis (Stratagene) and the 
mutagenic primers 5’-CAAAGGCTATATGGAACTGGATAA TGGACTGTA-3’, 5’-
CAAAGGCTATATGGGAGTGGATAATGGACTGTAC-3’, and 5’-
CAAAGGCTATATGGCTGTGGATAATGGACTGTAC-3’ and their complement 
for Q304N, Q304E, and Q304L respectively.  Mutagenesis was confirmed by 
sequencing. 
Transcription reporter assay:  This assay has been previously described30.  
Briefly, this assay employs a lacZ reporter fused to the promoter of a pheromone 
specific gene (FUS1).  β-galactosidase activity was monitored using a 96-well 
plate reader with excitation at 485nm and emission at 535nm.  
Phospho-MAPK assay:  This assay has been previously described31.  Briefly, 
exponentially growing yeast were exposed to pheromone, samples are removed 
at designated time-points, treated with 10mM Sodium Azide, pelleted by 
centrifugation, and stored at -80C.  Cellular proteins were extracted with triacetic 
acid.  Protein samples are resolved on SDS-PAGE gels, transferred to 
nitrocellulose membranes, and probed with p42/44 phosphorylation specific 
antibody (Cell Signaling Technologies, 1:500).   
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Figures: 
 
Figure 1. Scheme of G-protein activation by a GPCR and 
inactivation a RGS protein: 
 Yeast mating pathway components are named in parenthesis. 
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Figure 2. Yeast Shmoo Formation:  
 Haploid yeast of opposite mating types secrete pheromones.  Yeast use 
pheromone concentration to sense the direction and proximity of a possible 
mating partner and orient their shmoo in the direction of the closest mating 
partner.  The two haploids fuse, forming a diploid cell. 
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Figure 3.  N-Sst2 dampens pheromone induced cell-cycle arrest:   
A.  Sst2 domain architecture and N-Sst2 truncation mutant.  B.  A representative 
Halo assay performed on sst2Δ yeast expressing either empty vector or N-SST2.  
Saturated cultures were plated on agar and paper discs spotted with identical 
pheromone concentrations were placed on each plate. The zone of growth 
inhibition was measured, the size of the paper disc was subtracted and the 
averages and standard deviation are represented in panel C.    Each experiment 
was performed in triplicate. 
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Figure 4. Sst2 deletion results in high basal activity and 
increased pheromone sensitivity.   
Wild type and sst2Δ were transformed with a multi-copy plasmid expressing lacZ 
under the control of the promoter of a pheromone-induced gene (FUS1).  3 
colonies from each strain were assayed in triplicate. The relative fluorescence 
was averaged and is plotted along with the SEM.  Each graph is normalized so 
that the highest value equals 100. Basal activity and a full dose response are 
shown in panels A and B, respectively.   
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Figure 5.  N-Sst2 dampens basal transcriptional induction: 
Basal pathway activity was measured with the FUS1-lacZ transcription reporter 
assay.  Five colonies of sst2Δ yeast expressing either empty vector or N-Sst2 
were assayed in quadruplicate.  The relative fluorescence was averaged and is 
plotted here with the SEM. The graph is normalized so that the highest value 
equals 100. 
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Figure 6.  N-Sst2 dampens transcription reporter assay basal 
and maximal activity: 
Pheromone dose response was measured with the FUS1-lacZ transcription 
reporter assay.  Five colonies of sst2Δ yeast expressing either empty vector or N-
Sst2 were exposed to a range of pheromone concentrations (0-10uM) and 
assayed in quadruplicate.  The relative fluorescence for each dose was averaged 
and fit to a sigmoid dose response curve and is plotted here with the SEM. The 
graph is normalized so that the highest value equals 100. 
 
 
 
 
-4 -3 -2 -1 0 1 2
0
25
50
75
100 sst2Δ
N-SST2
wt
log[alpha factor]uM
 19 
Figure 7.  N-Sst2 dampens MAPK activation: 
Phospho-MAPK western blots performed on sst2Δ yeast expressing either empty 
vector or N-Sst2 exposed to 3uM pheromone, collected at the indicated time 
intervals, and stored at -80C.  Protein extracts were resolved by SDS-PAGE, 
transferred to nitrocellulose and probed with an antibody that specifically 
recognizes phosphorylated versions of Kss1 and Fus3.  A representative 
experiment of a total of two is shown here. 
 
 
 
 
 
 
 
 
 
 
 20 
Figure 8: Receptor binding mutants dampen basal activity: 
As in figure 2, sst2Δ yeast were transformed with empty vector, N-Sst2, or 
mutant versions of N-Sst2.   Basal pathway activity was measured with the 
FUS1-lacZ transcription reporter assay.  Each bar represents the average of 5 
colonies, each assayed in quadruplicate.  The relative fluorescence was 
averaged for each data point and is plotted along with the SEM. The graph is 
normalized so that the highest value equals 100.  Due to the variability present in 
these 2 experiments, we show both here. 
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Figure 9. Receptor binding mutants of N-SST2 express poorly: 
Three colonies of sst2Δ cells expressing either empty vectors or indicated 
versions of N-SST2 were grown to mid-log growth and harvested.  After SDS 
protein extraction, samples were resolved via SDS-PAGE, transferred to 
nitrocellulose, and probed with an antibody that recognizes myc.  An antibody 
that recognizes the housekeeping protein Pgk1 was used to assess loading. 
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Figure 10. Is Sho1 required for N-Sst2 phenotype? 
As in figure 2, sho1Δ and sho1Δsst2Δ yeast were transformed with either empty 
vector or N-Sst2 and basal pathway activation was measured with the FUS1-lacZ 
transcription reporter assay.  Each bar represents the average of 4 colonies, 
each assayed in quadruplicate.  The relative fluorescence was averaged for each 
data point and is plotted along with the SEM. The graph is normalized so that the 
highest value equals 100. 
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